View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

Appointment of Laetitia Brun as Chief Human Resources Officer of the E...

Appointment of Laetitia Brun as Chief Human Resources Officer of the Eramet Group, member of the Executive Committee Paris, December 17th, 2025, 8:30am PRESS RELEASE Appointment of Laetitia Brun as Chief Human Resources Officer of the Eramet Group, member of the Executive Committee Eramet announces the appointment of Laetitia Brun as Chief Human Resources Officer of the Group, effective February 9, 2026. In this capacity, she will become a member of the Executive Committee. She will succeed Anne-Marie Le Maignan, who has decided to retire after twenty-two years dedicated to supporting...

 PRESS RELEASE

Nomination de Laetitia Brun au poste de Directrice des Ressources Huma...

Nomination de Laetitia Brun au poste de Directrice des Ressources Humaines du Groupe Eramet, membre du Comité Exécutif Paris, le 17 Décembre, 2025, 8h30 COMMUNIQUÉ DE PRESSE Nomination de Laetitia Brun au poste de Directrice des Ressources Humaines du Groupe Eramet, membre du Comité Exécutif Eramet annonce la nomination de Laetitia Brun au poste de Directrice des Ressources Humaines du Groupe, à compter du 9 février 2026. À ce titre, elle deviendra membre du Comité Exécutif. Elle succédera à Anne-Marie Le Maignan, qui a décidé de prendre sa retraite après vingt-deux années consacrées ...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats.We are delighted to announce the acquisition of an innovative drug from Norbrook to stabilize feline hyperthyroidism. Virbac will ensure the direct distribution of this treatment under the Thyronorm brand in the United Kingdom, Australia, and New Zealand, and under the Felanorm brand in the United States. In Europe, distribution will continue to be managed by Boehringer Ingelheim and Elanco (in Germany) b...

 PRESS RELEASE

VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm

VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Cette acquisition apporte à Virbac un produit de spécialité de premier plan, sur un segment en croissance, pour améliorer la qualité de vie des chats âgés.Nous sommes ravis d'annoncer l'acquisition auprès de Norbrook d’un médicament innovant pour stabiliser l'hyperthyroïdie féline. Virbac assurera la distribution directe de ce traitement sous la marque Thyronorm au Royaume-Uni, en Australie et Nouvelle-Zélande ainsi qu’aux États-Unis sous la marque Felanorm,. En Europe, la distribution restera gérée par Boehringer Ingelheim et Elanco...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Flow Traders: Stronger November market value and volatility; KPN: Collective labour agreement over 18 months with a total salary increase of 5%; Theon International: 99% subscribed, rump covered; VÅR ENERGI: Good old Ekofisk.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch